Discount Generic Prescription Study

April 16, 2012 updated by: M.D. Anderson Cancer Center

Discount Generic Prescription Utilization in Low-income Populations

The goal of this study is to learn about the factors that influence people to take part in discount generic prescription programs.

The primary objective of this study is to identify the factors associated with awareness and utilization of discount generic prescription programs and how two low-income populations in Houston utilize the $4 for a 30-day supply or $10 for a 90-day supply, Generic Prescriptions Program offered by Kroger, Randalls, Target, Walmart, HEB, CVS, and Walgreens.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

If you agree to take part in this study, you will take part in a focus group. The focus group will consist of about 8 people who will discuss beliefs about generic medication, awareness of discount generic prescription programs, and use of the discount generic prescription program. The focus group will last about 90 minutes.

During the focus group, you will complete a form that asks for basic demographic information (such as your age and sex).

The focus group discussions will be taped, and the recorded tapes will be transcribed word-for-word. The taped recording of the focus group study will be stored in a safe and secured locker by the study chair. The taped recordings will be destroyed after 5 years.

Length of Study:

Your participation on this study will end once you complete the focus group.

This is an investigational study.

Study Type

Observational

Enrollment (Actual)

574

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77018
        • Independence Heights Community Health Center
      • Houston, Texas, United States, 77036
        • Hope Clinic
      • Houston, Texas, United States, 77477
        • Second Mile Mission Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults or an adult's family member, over the age of 18, with a low-income (less than $30,000/year) and a chronic health condition requiring prescriptions.

Description

Inclusion Criteria:

  • Age 18 and older
  • Low-income (less than $30,000/year)
  • Ability to speak English
  • Ability to read and write in English
  • Chronic health condition requiring prescription medication or family member with chronic health condition requiring prescription medication.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Low-income Populations
Behavioral: Survey
20 minute survey to determine the relationship between awareness of the discount generic prescription program and utilization of the program.
Other Names:
  • Questionnaire
Behavioral: Focus Group
5 - 8 focus groups of 6 - 10 people, lasting approximately 90 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of low-income adults who are aware of discount generic prescription programs (Survey)
Time Frame: 12 Months (estimated survey completion time 20 minutes)
12 Months (estimated survey completion time 20 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Investigators

  • Study Chair: Lovell A. Jones, PHD, BS, MA, UT MD Anderson Cancer Center
  • Principal Investigator: Anthony Omojasola, DRPH, UT MD Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

May 1, 2011

Study Registration Dates

First Submitted

September 2, 2009

First Submitted That Met QC Criteria

September 2, 2009

First Posted (Estimate)

September 3, 2009

Study Record Updates

Last Update Posted (Estimate)

April 18, 2012

Last Update Submitted That Met QC Criteria

April 16, 2012

Last Verified

April 1, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2009-0340

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low-Income Population

Clinical Trials on Survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe